Posts Tagged: Industry
As part of a cross-sector collaboration between U of T Engineering, the Reach Alliance, and Mexico-based GSE Biomedical, BME PhD student Samantha Unger contributes to a social impact market analysis aimed at improving access to self-sampling diagnostic devices across regions with limited health infrastructure. Her work helps bridge research and practical implementation, an essential step in closing critical care gaps.
AmacaThera Inc. (co-founded by Prof. Molly Shoichet), a biotechnology company focused on hydrogel-based drug delivery systems, has entered into an exclusive worldwide licensing agreement with Pacira BioSciences, Inc. for the development and commercialization of AMT-143, an investigational long-acting non-opioid anesthetic intended for post-operative pain management.
Cohesys is a Toronto-based medical device startup revolutionizing how surgeons treat facial fractures. Spun out of research at the University of Toronto’s Institute of Biomedical Engineering, Cohesys was founded by alumni Alex Jucan and Michael Floros. Their flagship innovation, BoneTape, is a flexible surgical adhesive designed to replace traditional metal plates and screws in craniomaxillofacial procedures.
Q&A: Why CCRM invests in future biomedical engineers March 27, 2025 Share on Email Share on LinkedIn As a leader in regenerative medicine commercialization in Canada, CCRM is committed to […]
Q&A: Why KITE-UHN invests in future biomedical engineers March 24, 2025 Share on Email Share on LinkedIn The KITE Research Institute at the Toronto Rehabilitation Institute—part of the University Health […]
Q&A: Why Fujifilm VisualSonics invests in future biomedical engineers March 20, 2025 Share on Email Share on LinkedIn For more than 25 years, Fujifilm VisualSonics has been at the forefront […]
The University of Toronto and its partners are receiving $4.25 million over the next five years to establish a national hub aimed at accelerating the commercialization of life sciences discoveries.
BME alum James Lazarovits' (BME 2019) startup Archon Biosciences debuts with $20M to advance Nobel-inspired protein technology in cancer treatment.
After completing her MHSc at BME in 2004, Dr. Amanda Mayo transitioned into medicine, specializing in Physiatry, also known as Physical Medicine and Rehabilitation. Recently promoted to Chief of the St. John’s Rehab Program at Sunnybrook Health Sciences Centre, Dr. Mayo has dedicated over a decade to advancing patient care, collaborating on accessible prosthetics, and leading and mentoring in her field.
The Entrepreneurship for Cardiovascular Health Opportunities (ECHO) Program was founded by Dr. Soror Sharifpoor in 2018. Aimed at improving cardiovascular research commercialization, this 12-month program includes workshops, webinars, networking, and mentorship activities, culminating in a public pitch competition where ventures can win $250,000 in startup funding.
Showing 1 - 10 of 26 results